ChristianTRuffMD
Cardiology • Boston, MACardiovascular Disease Genetics
Director of General Cardiology, Brigham and Women's Hospital; Senior Investigator, TIMI Study Group; Associate Professor of Medicine, Harvard Medical School
Dr. Ruff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Brigham & Women's Hospital
Boston, MA 02115Phone+1 617-732-6660
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2006 - 2009- Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2006
Johns Hopkins University School of MedicineClass of 2003
Certifications & Licensure
MA State Medical License 2005 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 1 citationsEffects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.Sunil V Badve, Anika Bilal, Matthew M Y Lee, Naveed Sattar, Hertzel C Gerstein
The Lancet. Diabetes & Endocrinology. 2024-11-25 - Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design.Sneha S Jain, Kenneth W Mahaffey, Karen S Pieper, Wataru Shimizu, Tatjana Potpara
American Heart Journal. 2024-11-01 - 1 citationsHeart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF.Paul M Haller, Petr Jarolim, Michael G Palazzolo, Andrea Bellavia, Elliott M Antman
Journal of the American College of Cardiology. 2024-10-15
Journal Articles
- Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesStephen D Wiviott, Marc S Sabatine, Christian T Ruff, Marc P Bonaca, Deepak L Bhatt, Darren K McGuire, The New England Journal of Medicine
- Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsErin A Bohula, Stephen D Wiviott, Benjamin M Scirica, Darren K McGuire, Marc S Sabatine, Marc P Bonaca, Christian T Ruff, Silvio E Inzucchi, The New England Journal of Medicine
Press Mentions
Anthos Presents New Analysis from P2 AZALEA-TIMI 71 StudyNovember 18th, 2024- As Blood Pressure Medicine Recalled Due to Cancer Risk, Here Are Similar Recalls and Why They Happened — Eat This Not ThatJanuary 3rd, 2023
- As Blood Pressure Medicine Recalled Due to Cancer Risk, Here Are Similar Recalls and Why They HappenedJanuary 2nd, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
